GeNext Genomics Pvt Ltd

One-stop solution for your antibody and protein needs.

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Below we have shared a video breaking down GNG's comp­­­­­­lete biosimilar development pipeline. For a biopharma CEO, a biosimilar licensing lead, or a CDMO evaluating upstream CRO partners, these 3 mins could redefine your development strategy. Visit: https://t.co/egYsyL5xYF

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GeNext Genomics (GNG) delivers high-affinity antibodies and scFv fragments purpose-built for CAR construct design, from antigen development to sequence delivery, entirely under one roof. DM: [email protected] | https://t.co/7DpPG44WFn #CARTherapy

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GNG offers comprehensive antibody production service, designed to support from research reagents to advanced therapeutic candidates – Hybridoma Generation | Recombinant Engineering | End-to-End Production | Comprehensive QC |
DM: [email protected] | https://t.co/7DpPG44WFn

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Proud moment for #TeamGNG! We're delighted to share that Anushka Atre from GNG has been selected to represent the Nagpur District Senior Women's Football Team at the Maharashtra State (WIFA) Inter-District Football Championship, being held in Jalgaon from August 21–26, 2026.

[GeNext Genomics Pvt Ltd @GeNextGenomics]

We're honoured to share that GeNext Genomics Pvt. Ltd has won BioPharma Project of the Year for our novel antibody discovery work on the HIND® Platform at the India Vaccine Leaders Conclave (IVLC), Hyatt Pune, 20 August 2026. DM: [email protected] | https://t.co/7DpPG44WFn

[GeNext Genomics Pvt Ltd @GeNextGenomics]

At GeNext Genomics Pvt Ltd, we utilise the Octet® Biolayer Interferometry (BLI) system to provide a high-throughput, label-free solution for biologics discovery, development, QC, and manufacturing. DM: [email protected] | Visit: https://t.co/7DpPG44WFn

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Our LFA development platform is built to deliver high sensitivity & specificity for both antigen & antibody detection – validation of Pairs | Conjugation & labelling | Assembly & Prototyping | Validation & scale-up.
DM: [email protected] | https://t.co/7DpPG44WFn |

[GeNext Genomics Pvt Ltd @GeNextGenomics]

BLI Assay for DNA–RNA (ASO) Binding Kinetics – Sub-nanomolar affinity | Sub-5% variability | Four weeks, start to finish | KD = 5.128 × 10⁻¹⁰ M | <5% CV | 4 weeks, method dev to deployment | ICH-validated, dossier-ready |

DM: [email protected] | https://t.co/JDLaa76KtP

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GNG BLI-based binding assays answer all three:
Same-day results, ICH-aligned validation, and real-time kinetics precise enough to drive confident decisions. Same-Day Binding Data. Weeks Faster than Cell-Based Assays. DM: [email protected] | Visit: https://t.co/7DpPG44WFn

[GeNext Genomics Pvt Ltd @GeNextGenomics]

When developing complex molecules like mAbs and biosimilars, monitoring CQAs is non-negotiable. Our analytical suite relies on cutting-edge UPLC technology to deliver the precision your partners demand. DM: [email protected] | visit: https://t.co/JDLaa76KtP

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GeNext Genomics Pvt Ltd (GNG) offers customised recombinant protein production services leveraging both bacterial and mammalian expression platforms. DM us at [email protected] or visit webpage: https://t.co/F1ap9PscfJ

[GeNext Genomics Pvt Ltd @GeNextGenomics]

HIND® Platform: 100% native human sequences with maximum VH/VL gene usage diversity | 3x expanded epitope coverage derived from diverse pathogen exposure | Patent-eligible scFvs optimised for CAR-T and CAR-NK applications. Discover novel antibodies. Visit: https://t.co/2CyQmiONKK

[GeNext Genomics Pvt Ltd @GeNextGenomics]

Thank you so much for the shoutout! It is an absolute honour for GeNext Genomics Pvt Ltd to be featured alongside such phenomenal trailblazers like @ActImmuno , Huwel Lifesciences, PopVax, and CrisprBits Private Limited. Click here to read: https://t.co/Ca0c1zkDhY

[GeNext Genomics Pvt Ltd @GeNextGenomics]

At GeNext Genomics Pvt Ltd, we design and optimise custom enzyme-linked immunosorbent assays (ELISAs) tailored for robust analyte detection – Custom Design | Epitope Binning | Validation of Pairs | Targeted Optimisation. DM: [email protected] | https://t.co/pxffVLMs8R

[GeNext Genomics Pvt Ltd @GeNextGenomics]

New on our blog: Antibody Discovery Services for Biologic Drug Development – how phage display-driven antibody discovery accelerates the path from target identification to lead candidate built for research and therapeutic applications. Read here: https://t.co/osPoFRccYw

[GeNext Genomics Pvt Ltd @GeNextGenomics]

By combining proprietary mammalian cell culture with advanced recombinant expression, GeNext Genomics delivers smarter recombinant antibodies engineered for maximum clinical and commercial impact. Visit: https://t.co/AhZDPbRCZ2 | DM: [email protected]

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GeNext Genomics Pvt Ltd's SWIRUS™ is India’s first indigenous ASFV Rapid Antigen Detection Kit. Accurate results in just 10 - 15 minutes. Works on whole blood, serum, or plasma. DM us or visit the SWIRUS page: https://t.co/R16Wc3nxpq | DM: [email protected]

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GeNext Genomics Pvt Ltd built HIND® – a Human Immune Naïve Diversity library – to give novel antibody discovery programs a genuinely native starting point. Visit the webpage for details: https://t.co/2CyQmiONKK
DM: [email protected]

[GeNext Genomics Pvt Ltd @GeNextGenomics]

1 Partner. 3 Layers of Assurance. Zero Compromises on Vaccine Quality. We closed that gap by building an integrated, documentation-ready assurance program spanning chemical, molecular & genomic layers under one roof. DM: [email protected] | https://t.co/pxffVLMs8R

[GeNext Genomics Pvt Ltd @GeNextGenomics]

GeNext Genomics Pvt Ltd has developed a fully validated BLI-based assay for ASO (DNA-RNA) binding kinetics, built on the Sartorius | Octet®, engineered for pharma-grade rigour and regulatory-ready deployment from day one. DM: [email protected] | https://t.co/pxffVLMs8R